Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 774073211 | 7740732 | 11 | F | 20110114 | 20160728 | 20101227 | 20160808 | EXP | CA-ROCHE-GNE311575 | ROCHE | 30.83 | YR | F | Y | 0.00000 | 20160808 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 774073211 | 7740732 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062 | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 774073211 | 7740732 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0062 | 103976 | SOLUTION FOR INJECTION | |||||||
| 774073211 | 7740732 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0062 | 103976 | SOLUTION FOR INJECTION | |||||||
| 774073211 | 7740732 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 774073211 | 7740732 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 774073211 | 7740732 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 774073211 | 7740732 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | FOR 3 WEEKS | U | 0 | 40 | MG | Q3W | ||||||
| 774073211 | 7740732 | 8 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | ||||||||||||
| 774073211 | 7740732 | 9 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 774073211 | 7740732 | 10 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 774073211 | 7740732 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 774073211 | 7740732 | 12 | C | PARIET | RABEPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 774073211 | 7740732 | 1 | Asthma |
| 774073211 | 7740732 | 7 | Product used for unknown indication |
| 774073211 | 7740732 | 8 | Product used for unknown indication |
| 774073211 | 7740732 | 9 | Product used for unknown indication |
| 774073211 | 7740732 | 10 | Product used for unknown indication |
| 774073211 | 7740732 | 11 | Product used for unknown indication |
| 774073211 | 7740732 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 774073211 | 7740732 | HO |
| 774073211 | 7740732 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 774073211 | 7740732 | Abdominal discomfort | |
| 774073211 | 7740732 | Asthma | |
| 774073211 | 7740732 | Body temperature decreased | |
| 774073211 | 7740732 | Bronchitis | |
| 774073211 | 7740732 | Cough | |
| 774073211 | 7740732 | Dyspnoea | |
| 774073211 | 7740732 | Heart rate increased | |
| 774073211 | 7740732 | Influenza like illness | |
| 774073211 | 7740732 | Obstructive airways disorder | |
| 774073211 | 7740732 | Pulmonary function test abnormal | |
| 774073211 | 7740732 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 774073211 | 7740732 | 1 | 20100111 | 0 | ||
| 774073211 | 7740732 | 2 | 20130611 | 0 | ||
| 774073211 | 7740732 | 3 | 20131126 | 0 | ||
| 774073211 | 7740732 | 4 | 20131224 | 0 | ||
| 774073211 | 7740732 | 5 | 20140814 | 0 | ||
| 774073211 | 7740732 | 6 | 20160408 | 0 | ||
| 774073211 | 7740732 | 7 | 20150306 | 0 |